Clinical trials
Recruiting Phase 2 trials in Mexico
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
58 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2017 | 2 |
| 2018 | 3 |
| 2019 | 1 |
| 2021 | 1 |
| 2022 | 5 |
| 2023 | 2 |
| 2024 | 6 |
| 2025 | 22 |
| 2026 | 16 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 58 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Eli Lilly and Company | 7 |
| Hoffmann-La Roche | 7 |
| Hospital Universitario Dr. Jose E. Gonzalez | 5 |
| AstraZeneca | 4 |
| Boehringer Ingelheim | 2 |
| Clarent Biopharma, Inc. | 2 |
| Instituto Nacional de Cancerologia de Mexico | 2 |
| Merck Sharp & Dohme LLC | 2 |
| National Institute of Allergy and Infectious Diseases (NIAID) | 2 |
| Sanofi | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Colitis, Ulcerative | 4 |
| Asthma | 3 |
| Lung Diseases | 3 |
| Arthritis, Rheumatoid | 2 |
| Breast Neoplasms | 2 |
| Inflammatory Bowel Diseases | 2 |
| Irritable Bowel Syndrome | 2 |
| Lupus Erythematosus, Systemic | 2 |
| Lupus Nephritis | 2 |
| Pulmonary Disease, Chronic Obstructive | 2 |
Trials
Showing 1 to 25 of 58. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.